• Latest Posts
Opinion 1 Nov 2023

Could this be the start of a new era for PI3K drugs?

In Depth 28 Sep 2023

Obesity drug success sparks biotech buying spree

Hope for Alzheimer’s patients after Lilly drug results


Lilly boosts obesity portfolio with Versanis Bio acquisition

BioGeneration Ventures closes BGV Fund V at €150M 

FDA approves type 2 diabetes drug for children 10 and older

Positive study results: Lilly’s Alzheimer’s drug slows patients’ decline 

5 advancements in kidney disease research over the past year

Lilly to develop Confo pain drug